![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/337 | |
A61K 31/255 | |||
A61P 35/02 | |||
A61K 33/24 | |||
A61K 45/06 |
(11) | Number of the document | 2249826 |
(13) | Kind of document | T |
(96) | European patent application number | 08794507.7 |
Date of filing the European patent application | 2008-07-15 | |
(97) | Date of publication of the European application | 2010-11-17 |
(45) | Date of publication and mention of the grant of the patent | 2016-09-07 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2008/008647 |
Date | 2008-07-15 |
(87) | Number | WO 2009/113989 |
Date | 2009-09-17 |
(30) | Number | Date | Country code |
75980 | 2008-03-14 | US | |
PCT/US2008/0034 | 2008-03-14 | WO |
(72) |
HAUSHEER, Frederick, H., US
|
(73) |
BIONUMERIK PHARMACEUTICALS, INC.,
8023 Vantage Drive Suite - Lobby 1, San Antonio, TX 78230,
US
|
(54) | COMPOSITIONS AND METHODS OF USE OF COMPOUNDS TO INCREASE CANCER PATIENT SURVIVAL TIME |
COMPOSITIONS AND METHODS OF USE OF COMPOUNDS TO INCREASE CANCER PATIENT SURVIVAL TIME |